Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sensitivity of BRCA1/2 mutation testing in 466 breast/ovarian cancer families.

Journal of medical genetics - 1 Sept 2003

Evans D G R, Bulman M, Young K, Gokhale D, Lalloo F

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bayes Theorem
Share to BRCA1 Protein
Share to BRCA2 Protein
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Family Health

Share to Ovarian Neoplasms

Share to Polymorphism, Single-Stranded Conformational

Share to Sensitivity and Specificity

Source

Open in PubMed Open full text

Identifiers

PMID: 12960223
DOI: 10.1136/jmg.40.9.e107
PMCID: PMC1735589

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sensitivity of BRCA1/2 mutation testing in 466 breast/ovarian cancer families.PMID 12960223Read ↗

BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction modelsSemantic proximity Read ↗

Testing for BRCA1/2 Mutations.Semantic proximity Read ↗

BRCA1 and BRCA2 Testing Among Young Breast Cancer Survivors.Semantic proximity Read ↗

BRCA1-BRCA2 mutation analysis results in 910 individuals: Mutation distribution and 8 novel mutations.Semantic proximity Read ↗

The role of testing for BRCA1 and BRCA2 mutations in cancer prevention.Semantic proximity Read ↗

Availability and payer coverage of BRCA1/2 tests and gene panels.Semantic proximity Read ↗

Prevalence of BRCA2 mutations in a hospital based series of unselected breast cancer cases.Semantic proximity Read ↗

BRCA1/2 testing: uptake, phenocopies, and strategies to improve detection rates in initially negative families.Semantic proximity Read ↗

Real-world multi-country study of BRCA1/2 mutation testing among adult women with HER2-negative advanced breast cancer.Semantic proximity Read ↗

BRCA1/2 Mutation Testing Among Adult Women With HER2-Negative Advanced Breast Cancer: Results From a Multi-Country, Real-World StudySemantic proximity Read ↗

Efficacy versus effectiveness of clinical genetic testing criteria for BRCA1 and BRCA2 hereditary mutations in incident breast cancer.Semantic proximity Read ↗

BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.